We’ve all heard of Ozempic by now. It’s only licensed for use as an injectable diabetes treatment in the UK and US, but it’s widely used ‘off label’ to help people lose weight. So much so in fact, tha

MULTIPLYING WEIGHT-LOSS MEDS WHEN MIKE DOUSTDAR STARTED AS A SUMMER EMPLOYEE making copies at Novo Nordisk—a teenager living in Austria after fleeing unrest in his home country of Iran at 12—he never

Centrica focuses on investment: Lower energy prices weighed on Centrica’s full-year earnings for 2025, which fell 40% from a year earlier, says Rachel Millard in the Financial Times. The owner of Brit

Snap election called: Danish prime minister Mette Frederiksen (pictured) has announced a snap election for 24 March, saying the next four years are “decisive” for her country, says Paulin Kola on BBC

Would she live happily ever after (the jabs)?

From those lacing up their trainers after losing weight to anyone considering medication as a route to faster race times, the use of GLP-1s in the running community is on the rise. But weighing any potential benefits with the inherent dangers is a delicate balancing act